Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025Clinical Infectious DiseasesOpen Access

The Role of β-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical Trials

View Full Paper
Ask AI
Bookmark
Share

Authors

KDKhalid M DousaESEunjeong ShinSKSebastian G. Kurz

Discussion

Loading...

Member takes

Overview

Review finds β-lactam antibiotics potentially effective against drug-resistant Mycobacterium abscessus, suggesting new clinical trial designs.

Key Points

  • Research supports potential efficacy of β-lactam antibiotics against mycobacterium abscessus, indicating a shift in treatment strategies.
  • In vitro studies and clinical case reviews underline the importance of β-lactamase inhibitors in enhancing antibiotic effectiveness against non-tuberculous mycobacteria.
  • Detailed enzymatic pathways and mechanisms of β-lactam action on peptidoglycan synthesis reveal new therapeutic avenues worth exploring in clinical contexts.
  • The review synthesizes over a decade of laboratory insights, emphasizing the need for innovative clinical trial designs focusing on β-lactam/β-lactamase inhibitor combinations.

Cite This Study

Dousa et al. (2025) studied this question.

synapsesocial.com/papers/68dd91cffe798ba2fc498db5https://doi.org/10.1093/cid/ciaf547
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The promise and pitfalls: interpreting dual β-lactam success in <i>Mycobacterium abscessus</i> with caution2025
  2. 2Multipronged Cell Wall-Targeting Converts Ineffective Antibiotics into a Potent Regimen against <i>Mycobacterium abscessus</i>2026
  3. 3Activity of combinations of bactericidal and bacteriostatic compounds in Mycobacterium abscessus-infected mice: an overview2025
  4. 4Combinations comprising dual β-lactams and a β-lactamase inhibitor achieve optimal synergistic inhibition of 2025
  5. 5<i>In vitro</i> efficacy of sulbactam/durlobactam combined with β-lactam antibiotics in Australian <i>Mycobacterium abscessus</i> isolates2025 · 1 citations